Ultrasonic Imaging and Drug Propulsion Into Tumors Using Genetically Encoded Gas Nanostructures

Project Information

TheraSonix

Grant agreement ID: 792866

DOI 10.3030/792866

Project terminated on 30 November 2021

EC signature date 28 March 2018

Start date 1 May 2018

End date 31 January 2022

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 263 385,00

EU contribution € 263 385,00

Coordinated by

TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD
Israel

Publications

Peer reviewed articles (3)

Ultrasensitive ultrasound imaging of gene expression with signal unmixing

Author(s): Daniel P. Sawyer, Avinoam Bar-Zion, Arash Farhadi, Shirin Shivaei, Bill Ling, Audrey Lee-Gosselin & Mikhail G. Shapiro
Published in: Nature Methods, Issue 18.8, 2021, Page(s) 945-952, ISSN 1548-7091
Publisher: Nature Publishing Group
DOI: 10.1038/s41592-021-01229-w

Acoustically triggered mechanotherapy using genetically encoded gas vesicles

Author(s): Avinoam Bar-Zion, Atousa Nourmahnad, David R. Mittelstein, Shirin Shivaei, Sangjin Yoo, Marjorie Buss, Robert Hurt, Dina Malounda, Mohamad Abedi, Audrey Lee-Gosselin, Margaret Swift, David Maresca, Mikhail G. Shapiro
Published in: Nature nanotechnology, Issue 16.12, 2021, Page(s) 1403-1412, ISSN 1748-3387
Publisher: Nature Publishing Group
DOI: 10.1101/620567

Achieving Spatial and Molecular Specificity with Ultrasound-Targeted Biomolecular Nanotherapeutics

Author(s): Jerzy O. Szablowski, Avinoam Bar-Zion, Mikhail G. Shapiro
Published in: Accounts of Chemical Research, Issue 52/9, 2019, Page(s) 2427-2434, ISSN 0001-4842
Publisher: American Chemical Society
DOI: 10.1021/acs.accounts.9b00277